Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis

Seminars in Arthritis and Rheumatism

Volumn 26, Issue 2, 1996, Pages 526-538

  Badolato, R ^a   Oppenheim, J J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

acute phase proteins; chemokines; Cytokines; inflammation

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0029965602     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(96)80041-2     Document Type: Article

References (143)

1. Talal N. Molecular Autoimmunity 1991 Academic Press London, San Diego
2. (suppl) Lipsky P.E. Immunopathogenesis and treatment of rheumatoid arthritis J Rheumatol 32 1992 92 94
3. Spector T.D. Rheumatoid arthritis Rheum Dis Clin North Am 16 1990 513 537
4. Eastgate J.A. Symons J.A. Wood N.C. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis Lancet 2 1988 706 709
5. Houssiau F.A. Devogelaer J.P. Van Damme J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritis Arthritis Rheum 31 1988 784 788
6. Pettipher E.R. Higgs G.A. Henderson B. Interleukin-1 induces leukocytes infiltration and cartilage proteoglycan degradation in the synovial joint Proc Natl Acad Sci USA 83 1986 8749 8753
7. Schultz D.R. Arnold P.I. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, α1-acid glycoprotein, and fibrinogen Semin Arthritis Rheum 20 1990 129 147
8. Heinrich P.C. Castell J.V. Andus T. Interleukin-6 and the acute phase response Biochem J 265 1990 621 636
9. Andus T. Geiger T. Hirano T. Regulation of synthesis and secretion of major rat acute-phase proteins by recombinant human interleukin-6 (BSF-2/IL-6) in hepatocyte primarycultures Eur J Biochem 173 1988 287 293
10. Gauldie J. Richards C. Hamish D. Lansdorp P. Baumann H. Interferon beta 2/B cell stimulatory factor type-2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells Proc Natl Acad Sci (USA) 84 1987 7251 7255
11. Badolato R. Wang J.M. Murphy W.J. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes J Exp Med 180 1994 203 209
12. 2-microglobulin-like proteins Science 243 1989 655 657
13. Mitchell T.I. Coon C.I. Brinckerhoff C.E. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin with specific antiserum J Clin Invest 87 1991 1177 1185
14. Koch A.E. Kunkel S.L. Burrows J.C. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8 J Immunol 147 1991 2187 2195
15. Brennan F.M. Zachariae C.O. Chantry D. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of IL-8 mRNA by isolatedsynovial cells Eur J Immunol 20 1990 2141 2144
16. Koch A.E. Kunkel S.L. Harlow L.A. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis J Clin Invest 90 1992 772 779
17. Akahoshi T. Wada C. Endo H. Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Regulation of its production in synovial cells by interleukin-1and tumor necrosis factor Arthritis Rheum 36 1993 762 771
18. Koch A.E. Kunkel S.L. Harlow L.A. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis J Clin Invest 93 1994 921 928
19. Rathanaswami P. Hachicha M. Sadick M. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines J Biol Chem 268 1993 5834 5839
20. Nouri A.M.E. Panayi G.S. Goodman S.M. Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids Clin Exp Immunol 55 1984 295
21. Duff G.W. Dickens E. Wood N. Immunoassay, bioassay and in situ hybridization of monokines in human arthritis Powanda Oppenheim J.J. Kluger M.J. Dinarello C.A. Monokines and Other Non-Lymphocytic Cytokines 1988 Alan R Liss M.C. New York, NY
22. Di Giovine F. Nuki G. Duff G. Tumor Necrosis Factor in synovial exudates Ann Rheum Dis 47 1988 768
23. MacNaul K.L. Hutchinson N.I. Parsons J.N. Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization J Immunol 145 1990 4154 4166
24. [published erratum appears in J Immunol 145:1037, 1990] Firestein G.S. Alvaro Gracia J.M. Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis J Immunol 144 1990 3347 3353
25. Henderson B. Pettipher E.R. Arthritogenic actions of recombinant IL-1 and tumor necrosis factor in the rabbit: evidence for synergistic interactions between cytokines in vivo Clin Exp Immunol 75 1989 306 310
26. MacNaul K.L. Chartrain N. Lark M. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of stromelysin, collagenase, and tissue inhibitor of metalloprotemases-1in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression J Biol Chem 265 1990 17238 17245
27. Dayer J.M. Beutler B. Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by synovial cells and dermal fibroblasts J Exp Med 162 1985 2163
28. 2 production by human synovial cells and dermal fibroblasts J Clin Invest 77 1986 645
29. Saklatvala J. Tumor necrosis factor stimulates resorption and inhibits synthesis of proteoglycan in cartilage Nature 322 1986 547 549
30. Gowen M. Wood D.D. Ihrie E.J. An interleukin-1 like factor stimulates bone resorption in vitro Nature 306 1983 378 380
31. Walakovits L.A. Moore V.L. Bhardwaj N. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and post traumatic knee injury Arthritis Rheum 35 1992 1076 1084
32. Gravellese E.M. Darling J.M. Ladd A.L. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium Arthritis Rheum 34 1991 1076 1084
33. Janusz M.J. Hare M. Cartilage degradation by cocultures of transformed macrophage and fibroblast cell lines. A model of metalloproteinase-mediated connective tissue degradation J Immunol 150 1993 1922 1931
34. Guerne P.A. Zuraw B.L. Vaughan J.H.J. Synovium as a source of interleukin 6 in vitro . Contribution to local and systemic manifestations of arthritis J Clin Invest 83 1989 585 592
35. Bhardwaj N. Santhanam U. Lau L.L. IL-6/IFN-beta 2 in synovial effusions of patients with rheumatoid arthritis and arthritides. Identification of several isoforms and studies of cellular sources J Immunol 143 1989 2153 2159
36. Wood N.C. Symons J.A. Dickens E. In situ hybridization of IL-6 in rheumatoid arthritis Clin Exp Immunol 87 1992 183 189
37. Ito A. Itoh Y. Sasaguri Y. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts Arthritis Rheum 35 1992 1197 1201
38. Hirano T. Interleukin-6 and its relation to inflammation and disease Clin Immunol Immunopathol 62 1992 S60 S65
39. Neben S. Turner K. The biology of interleukin-11 Stem Cells Dayt 11 suppl 2 1993 156 162
40. Villiger P.M. Geng Y. Lotz M. Induction of cytokine expression by leukemia inhibitory factor J Clinic Invest 91 1993 1575 1581
41. Madhok R. Crilly A. Watson J. Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity Ann Rheum Dis 52 1993 232 234
42. Hovdenes J. Kvien T.K. Hovdenes A.B. IL-6 in synovial fluids, plasma and supernatants from cultured cells or patients with rheumatoid arthritis and other inflammatory arthritides Scand J Rheumatol 19 1990 177 182
43. Yoshida K. Kobayashi K. Yamagata N. Inflammatory cytokines and enzymes in synovial fluid of patients with rheumatoid arthritis and other arthritides Int Arch Allergy Immunol 98 1992 286 292
44. Pelletier J.P. Di Battista J.A. Roughly P. Cytokines and inflammation in cartilage degradation Rheum Dis Clin North Am 19 1993 545 568
45. Thonar E.J. Shinmei M. Lohmander L.S. Body fluid markers of cartilage changes in osteoarthritis Rheum Dis Clin North Am 19 1993 635 657
46. Towle C.A. Trice M.E. Regulation of cartilage remodelling by IL-1: evidence for autocrine synthesis of IL-1 by chondrocytes J Rheumatol 14 1987 11 13
47. Westacott C.I. Whicher J.T. Barnes I.C. Synovial fluid concentration of five different cytokines in rheumatic diseases Ann Rheum Dis 49 1990 676 681
48. Swaak A.J. Van Rooyen A. Nieuwenhuis E. Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases Scand J Rheumatol 17 1988 469 474
49. Chu C.Q. Field M. Allard S. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair Br J Rheumatol 31 1992 653 661
50. Beckham J.C. Caldwell D.S. Peterson B.L. Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures J Clin Immunol 12 1992 353 361
51. (editorial) Vignon E. Serum markers of osteoarthrosis. From theory to practice Rev Rhum Mal Osteoartic 59 1992 457 459
52. (suppl) Loose L.D. de Oliveira R. Sipe J.D. A possible systemic component of osteoarthritis (OA): elevated concentrations (by ELISA) of C-reactive protein (CRP) in serum of OA patients and modulation by tenidap Arthritis Rheum 36 1993 S166
53. (abstr; in press) Hart D.J. Nandra D. Manzi C. The role of subclinical inflammation in early knee osteoarthritis and progression of disease Arthritis Rheum 1995
54. Le J.M. Vilcek J. Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase response Lab Invest 61 1989 588 602
55. Gauldie J. Interleukin-1 in the acute phase response Pepys M.B. Acute Phase Proteins in the Acute Phase Response 1988 Springer Verlag London
56. Rokita H. Loose L.D. Bartle L.M. Synergism of interleukin 1 and interleukin 6 induces serum amyloid A (SAA) production while depressing fibrinogen: a quantitative analysis J Rheumatol 21 1994 400 405
57. Baumann H. Gauldie J. The acute phase response Immunol Today 15 1994 74 80
58. Steel D.M. Whitehead A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein Immunol Today 15 1994 81 88
59. Ganapathi M.K. May L.T. Schultz D. Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines Biochem Biophys Res Commun 157 1988 271 277
60. Ganapathi M.K. Schultz D. Mackiewicz A. Heterogeneous nature of the acute phase response. Differential regulation of human serum amyloid A, C-reactive protein, and other acute phaseproteins by cytokines in Hep 3B cells J Immunol 141 1988 564 569
61. Ganapathi M.K. Rzewnicki D. Samols D. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells J Immunol 147 1991 1261 1265
62. Kushner I. Regulation of the acute phase response by cytokines Perspect Biol Med 36 1993 611 622
63. Goldberger G. Bing D.H. Sipe J.D. Transcriptional regulation of genes encoding the acute-phase proteins CRP, SAA and C3 J Immunol 138 1987 3967 3971
64. Garter U. Arcone R. Toniatti C. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6 EMBO J 8 1989 3773 3779
65. Meek R.L. Benditt E.P. Rat tissues express serum amyloid A protein-related mRNAs Proc Natl Acad Sci USA 86 1989 1890 1894
66. Sack G.H. Jr Zink M.C. Serum amyloid A gene transcription in synovial cells during retroviral arthritis Am J Pathol 141 1992 525 529
67. Brevario F. d'Aniello E. Golay J. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component J Biol Chem 267 1992 22190 22197
68. Baird R.W. Bronze M.S. Kraus W. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium J Immunol 146 1991 3132 3137
69. Athanasou N.A. Sallie B. Localized deposition of amyloid in articular cartilage Histopathology 20 1992 41 46
70. (in press) Badalato R. Johnston J.A. Wang J.M. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signalling pathway J Immunol 1995
71. Vigushin D.M. Pepys M.B. Hawkins P.N. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease J Clin Invest 91 1993 1351 1357
72. Hutchinson W.L. Noble G.E. Hawkins P.N. The pentraxins, C-reactive protein and scrum amyloid P component, are cleared and catabolized by hepatocytes in vivo J Clin Invest 94 1994 1390 1396
73. (editorial) Kushner I. C-reactive protein in rheumatology Arthritis Rheum 34 1991 1065 1068
74. Mortensen R.F. Macrophages and acute-phase proteins Immunol Ser 60 1994 143 158
75. Tebo J.M. Mortensen R.F. Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937 J Immunol 144 1990 231 238
76. Galve de Rochemonteix B. Wiktorowicz K. Kushner I. C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages J Leukoc Biol 53 1993 439 445
77. Tilag H. Vannier E. Vachino G. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin-1 (IL-1) receptor antagonist over IL-1 synthesisby human peripheral blood mononuclear cells J Exp Med 178 1993 1629 1636
78. Månsson B. Carey D. Alini M. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers ofcartilage metabolism J Clin Invest 95 1995 1071 1077
79. van Leeuwen M.A. van der Heijde D.M.F.M. van Rijswijk M.H. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants J Rheumatol 21 1994 45 49
80. Hosaka S. Akahoshi T. Wada C. Expression of the chemokine superfamily in rheumatoid arthritis Clin Exp Immunol 97 1994 451 457
81. Koch A.E. Kunkel S.L. Harlow L.A. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis J Clin Invest 94 1994 1012 1019
82. Bedard P.A. Golds E.E. Cytokine-induced expression of mRNAs for chemotactic factors in human synovial cells and fibroblasts J Cell Physiol 154 1993 433 441
83. (letter) Snowden N. Hajeer A. Thompson W. RANTES role in rheumatoid arthritis Lancet 343 1994 547 548
84. Deleuran B.W. Chu C.O. Field M. Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial tissue andcartilage-pannus junction in rheumatoid arthritis Br J Rheumatol 31 1992 801 909
85. Deleuran B.W. Chu C.Q. Field M. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis.Implications for local actions of tumor necrosis factor alpha Arthritis Rheum 35 1992 1170 1178
86. Chu C.Q. Field M. Feldmann M. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis Arthritis Rheum 34 1991 1125 1132
87. Taub D.D. Conlon K. Lloyd A.R. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta Science 260 1993 355 358
88. Taub D.D. Oppenheim J.J. Review of the chemokine meeting the Third International Symposium of Chemotactic Cytokines Cytokine 5 1993 175 179
89. Unemori E.N. Amento E.P. Bauer E.A. Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts. Regulation by C-X-C but not C-C cytokines J Biol Chem 268 1993 1338 1342
90. Djeu J.Y. Matsushima K. Oppenheim J.J. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8 J Immunol 144 1990 2205 2210
91. Oppenheim J.J. Zachariae C.O.C. Mukaida N. Properties of the novel proinflammatory supergene “Intercrine” cytokine family Ann Rev Immunol 9 1991 617 648
92. Peichl P. Ceska M. Effenberger F. Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis Scand J Immunol 34 1991 333 339
93. Lindley I.J. Ceska M. Peichl P. NAP-1/IL-8 in rheumatoid arthritis Adv Exp Med Biol 305 1991 147 156
94. Seitz M. Dewald B. Gerber N. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis J Clin Invest 87 1991 463 469
95. Deleuran B. Lemche P. Kristensen M. Localisation of interleukin 8 in the synovial membrane, cartilagepannus junction and chondrocytes in rheumatoid arthritis Scand J Rheumatol 23 1994 2 7
96. Endo H. Akahoshi T. Nishimura A. Experimental arthritis induced by continuous infusion of IL-8 into rabbit knee joints Clin Exp Immunol 96 1994 31 35
97. Akahoshi T. Endo H. Kondo H. Essential involvement of interleukin-8 in neutrophil recruitment in rabbits with acute experimental arthritis induced by lipopolysaccharide andinterleukin-1 Lymphokine Cytokine Res 13 1994 113 116
98. Hogan M. Sherry B. Ritchlin C. Differential expression of the small inducible cytokines GRO alpha and GRO beta by synovial fibroblasts in chronic arthritis: possible role in growth regulation Cytokine 6 1994 61 69
99. Unemori E.N. Masters J.C. Bauer E.A. The product of the GRO gene regulates collagen turnover by inducing tissue inhibitor of metalloproteinases Arthritis Rheum 34 9 Suppl 1991 S117
100. Koch A.E. Polverini P.J. Kunkel S. Interleukin-8 as a macrophage-derived mediator of angiogenesis Science 258 1992 1798 1801
101. Bucala R. Ritchli C.N. Winchester R. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts J Exp Med 173 1991 569 574
102. Kumkumian G.K. Lafyatis R. Remmers E.F. Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription J Immunol 143 1989 833 837
103. Sano H. Engleka K. Mathern P. Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissuesof patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis J Clin Invest 91 1993 553 565
104. Hamerman D. Taylor S. Kirschebaum I. Growth factors with heparin binding affinity in human synovial fluid Proc Soc Exp Biol Med 186 1987 384 389
105. Fava R. Olsen N. Keski Oja J. Active and latent forms of transforming growth factor beta activity in synovial effusions J Exp Med 169 1989 291 296
106. Wilder R.L. Lafyatis R. Roberts A.B. Transforming growth factor-beta in rheumatoid arthritis Ann N Y Acad Sci 593 1990 197 207
107. Heindenreich S. Gong J. Schmidt A. Macrophage activation by granulocyte/macrophage colony stimulating factor- and prostaglandin E2 J Immunol 143 1989 1198 1204
108. Xu W.D. Firestein G.S. Taetle R. Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions J Clin Invest 83 1988 876 882
109. Alvaro Gracia J.M. Zvaifler N.J. Brown C.B. Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colonystimulating factorproduction and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha J Immunol 146 1991 3365 3371
110. Alvaro Gracia J.M. Zvaifler N.J. Firestein G.S. Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen onhuman monocytes: a possible role in rheumatoid arthritis J Exp Med 170 1989 865 875
111. Alvaro Gracia J.M. Zvaifler N.J. Firestein G.S. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes J Clin Invest 86 1990 1790 1798
112. Arend W.P. Interleukin-1 receptor antagonist Adv Immunol 54 1983 167 227
113. Olsson I. Gatanaga T. Gullberg U. Tumor necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy Eur Cytokine Netw 4 1993 169 180
114. Firestein G.S. Berger A.E. Tracey D.E. IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium J Immunol 149 1992 1054 1062
115. McColl S.R. Paquin R. Menard C. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha J Exp Med 176 1992 593 598
116. Williams R.O. Feldmann M. Maini R.N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proc Natl Acad Sci USA 89 1992 9784 9788
117. Williams R.O. Mason L.J. Feldmann M. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen induced arthritis Proc Natl Acad Sci USA 91 1994 2762 2766
118. Elliott M.J. Maim R.N. Feldmann M. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha Arthritis Rheum 36 1993 1681 1690
119. Elliott M.J. Maini R.N. New directions for biological therapy in rheumatoid arthritis Int Arch Allergy Immunol 104 1994 112 125
120. Maini R.N. Brennan F.M. Williams R. TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy Clin Exp Rheumatol 11 suppl 8 1999 S173 S175
121. Firestein G.S. Xu W.D. Townsend K. Cytokines in chronic inflammatory arthritis. I. Failure to detect T Cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophagecolony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis J Exp Med 168 1988 1573 1586
122. Sadouk M. Vaquero C. de la Tour B. Interferon-gamma mRNA expression upon in vitro T lymphocyte activation is decreased in rheumatoid arthritis patients Clin Immunol Immunopathol 56 1990 37 45
123. Hovdenes J. Gaudernack G. Kvien T.K. Mitogen-induced interleukin 2 and gamma interferon production by CD4+ and CD8+ cells of patients with inflammatory arthritides. A comparison between cells from synovial fluid and peripheral blood Scand J Immunol 30 1989 597 603
124. Hovdenes J. Hovdenes A.B. Egeland T. A study of the effect of rheumatoid synovial fluid on proliferation and IL-2 production by total mononuclear cells and purified CD4+ cells ofsynovial fluid and peripheral blood Scand J Rheumatol 19 1990 398 406
125. Simon A.K. Seipelt E. Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis Proc Natl Acad Sci USA 91 1994 8562 8566
126. Matthews N Emery P. Pilling D. Subpopulations of primed T helper cells in rheumatoid arthritis Arthritis Rheum 36 1993 603 607
127. Miltenberg A.M. van Laar J.M. de Kuiper R. T cells cloned from human rheumatoid synovial membrane functionally represent the TH1 subset Scand J Immunol 35 1992 603 610
128. Quayle A.J. Chomarat P. Miossec P. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns Scand J Immunol 38 1993 75 82
129. H2-like phenotype J Exp Med 179 1994 481 491
130. Rapoport M.J. Jamarillo A. Zipris D. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in non-obese diabetic mice J Exp Med 178 1993 87 99
131. (editorial) Miossec P. Anti-inflammatory properties of interleukin-4 Rev Rhum Ed Fr 60 1993 119 124
132. Miossec P. Briolay J. Dechanet J. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis Arthritis Rheum 35 1992 874 883
133. Seitz M. Loetscher P. Dewald B. Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes-regulation by IFN-gamma and IL-4 J Immunol 152 1994 2060 2065
134. Dechanet J. Briolay J. Rissoan M.C. IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle J Immunol 151 1993 4908 4917
135. Moore K.W. O'Garra A. de Waal Malefyt R. Interleukin-10 Ann Rev Immunol 11 1993 165 190
136. Katsikis P.D. Chu C.Q. Brennan F.M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis J Exp Med 179 1994 1517 1527
137. Cope A.P. Londei M. Chu N.R. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal invivo by anti-TNF antibodies in patients with rheumatoid arthritis J Clin Invest 94 1994 749 760
138. Sewell K.L. Trentham D.E. Pathogenesis of rheumatoid arthritis Lancet 341 1993 283 286
139. Wendling D. Racadot E. Wijdenes J. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody J Rheumatol 20 1993 259 262
140. Loose L.D. Sipe J.D. Kirby D.S. Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug Br J Rheumatol 32 suppl 3 1993 19 25
141. Sipe J.D. Bartle L.M. Loose L.D. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response J Immunol 148 1992 480 484
142. (suppl) Littman B.H. Drury C.E. Stewart C.R. Acute phase proteins and plasma IL-6 in patients with rheumatoid arthritis: Effects of tenidap and piroxicam in a 12 week double blind cross-overstudy Arthritis Rheum 36 1993 S112
143. Genant H.K. Kirby D.S. Pickering E.A. Tenidap slows X-ray deterioration in rheumatoid arthritis Arthritis Rheum 38 9 Suppl 1995 S330